Hudson Value Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.38M Sell
57,439
-1,758
-3% -$206K 1.85% 18
2026
Q1
$7.12M Buy
59,197
+860
+1% +$99.3K 2.13% 17
2025
Q4
$6.18M Sell
58,337
-494
-0.8% -$46.4K 1.84% 19
2025
Q3
$4.94M Sell
58,831
-2,852
-5% -$235K 1.53% 24
2025
Q2
$4.88M Sell
61,683
-21,628
-26% -$1.72M 1.68% 24
2025
Q1
$7.48M Buy
83,311
+37,347
+81% +$3.49M 2.81% 7
2024
Q4
$4.57M Sell
45,964
-2,660
-5% -$274K 1.7% 22
2024
Q3
$5.52M Buy
48,624
+4,363
+10% +$518K 2.15% 15
2024
Q2
$5.48M Sell
44,261
-175
-0.4% -$22.5K 2.32% 12
2024
Q1
$5.86M Sell
44,436
-53
-0.1% -$6.53K 2.49% 7
2023
Q4
$4.85M Buy
44,489
+1,794
+4% +$186K 2.26% 11
2023
Q3
$4.4M Buy
42,695
+351
+0.8% +$37.8K 2.31% 8
2023
Q2
$4.88M Buy
42,344
+1,248
+3% +$142K 2.5% 8
2023
Q1
$4.37M Buy
41,096
+60
+0.1% +$6.48K 2.49% 8
2022
Q4
$4.55M Buy
41,036
+353
+0.9% +$36.1K 2.8% 5
2022
Q3
$3.5M Buy
40,683
+55
+0.1% +$4.91K 2.36% 10
2022
Q2
$3.7M Buy
40,628
+9,146
+29% +$811K 2.35% 8
2022
Q1
$2.58M Buy
31,482
+579
+2% +$45.6K 1.33% 27
2021
Q4
$2.37M Buy
30,903
+3,163
+11% +$252K 1.15% 30
2021
Q3
$2.08M Buy
27,740
+330
+1% +$25.1K 1.15% 30
2021
Q2
$2.13M Buy
27,410
+1,344
+5% +$100K 1.18% 28
2021
Q1
$1.92M Buy
26,066
+6,595
+34% +$486K 1.16% 28
2020
Q4
$1.5M Buy
+19,471
New +$1.49M 1% 29

Other funds holding MRK

Hudson Value Partners's MRK Position: Q2 2026 in Review

Hudson Value Partners reduced its Merck (MRK) stake by 3% in Q2 2026, selling an estimated $206K and leaving 57,439 shares worth $7.38M. The position accounts for 1.85% of the portfolio, ranked #18.

Hudson Value Partners first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.48M in Q1 2025. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Hudson Value Partners held 57,439 shares of Merck worth $7.38M as of Q2 2026.
  • Hudson Value Partners sold 1,758 Merck shares in Q2 2026, an estimated $206K.
  • Merck made up 1.85% of Hudson Value Partners's portfolio in Q2 2026, its #18 holding.
  • Hudson Value Partners first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Hudson Value Partners's Merck position peaked at $7.48M in Q1 2025.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Hudson Value Partners's 13F filing for Q2 2026, filed 10 Jul 2026.